136 related articles for article (PubMed ID: 34814390)
41. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
42. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
43. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
Azizi F; Abdi H; Amouzegar A
BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
[TBL] [Abstract][Full Text] [Related]
44. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
[TBL] [Abstract][Full Text] [Related]
45. Role of colestipol in the treatment of hyperthyroidism.
Hagag P; Nissenbaum H; Weiss M
J Endocrinol Invest; 1998 Dec; 21(11):725-31. PubMed ID: 9972670
[TBL] [Abstract][Full Text] [Related]
46. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
[TBL] [Abstract][Full Text] [Related]
47. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study.
Nolte ; Muller R; Siggelkow H; Emrich D; Hufner M
Eur J Endocrinol; 1996 Mar; 134(3):337-41. PubMed ID: 8616532
[TBL] [Abstract][Full Text] [Related]
48. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
Cassidy CE
Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
[No Abstract] [Full Text] [Related]
49. Medical treatment of hyperthyroidism: state of the art.
Fumarola A; Di Fiore A; Dainelli M; Grani G; Calvanese A
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):678-84. PubMed ID: 20496313
[TBL] [Abstract][Full Text] [Related]
50. Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis.
Scappaticcio L; Longo M; Maiorino MI; Pernice V; Caruso P; Esposito K; Bellastella G
Thyroid; 2021 Jun; 31(6):884-894. PubMed ID: 33327837
[No Abstract] [Full Text] [Related]
51. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
[TBL] [Abstract][Full Text] [Related]
52. Exposure to antithyroid drugs and ethylenethiourea and risk of thyroid cancer: a systematic review of the epidemiologic evidence.
La Vecchia C; Turati F; Negri E
Eur J Cancer Prev; 2022 Jan; 31(1):64-72. PubMed ID: 33492873
[TBL] [Abstract][Full Text] [Related]
53. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
[TBL] [Abstract][Full Text] [Related]
54. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
55. A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma.
Ishihara T; Ikekubo K; Shimodahira M; Iwakura T; Kobayashi M; Hino M; Oobayashi M; Kohno K; Kimura K; Kawamura S; Kurahachi H
Endocr J; 2002 Apr; 49(2):241-5. PubMed ID: 12081245
[TBL] [Abstract][Full Text] [Related]
56. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
[TBL] [Abstract][Full Text] [Related]
57. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
[TBL] [Abstract][Full Text] [Related]
58. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
Stege R
Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
[No Abstract] [Full Text] [Related]
59. Efficacy of low-dose methimazole in control of multiple relapses of Graves' hyperthyroidism: a case report.
Azizi F; Amouzegar A; Abdi H
J Med Case Rep; 2021 Apr; 15(1):189. PubMed ID: 33888159
[TBL] [Abstract][Full Text] [Related]
60. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
